Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus - Wikidata - awgldk - TriplyDB

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

http://www.wikidata.org/entity/Q30368335

about

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines Immune mechanisms of protection: can adjuvants rise to the challenge?Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Universal immunity to influenza must outwit immune evasion Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses Preemptive priming readily overcomes structure-based mechanisms of virus escape Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.Refining the approach to vaccines against influenza A viruses with pandemic potential.Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.Influenza immunology evaluation and correlates of protection: a focus on vaccines.Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

P2860

Q21090076-9CF702E9-A75E-4CB9-BA95-30263ABBE0D1 Q21245319-07248742-A3C2-4119-B6FC-5DF4FCB32DE0 Q24648051-4FADE998-5E01-4E19-B8BF-C6D07762BE98 Q24655857-3FCF05B4-B8C4-42C3-BD55-3E15CFE8A22F Q26765927-1419F1CF-36E1-40B5-A67D-056ED18EB4A1 Q26767517-8682DACF-C208-423E-BA41-0C807D7EDB12 Q26783884-D46C67BD-BE34-4AB1-9E18-ADC6289AFFE2 Q26783897-A0BA1E11-2F6A-462B-9B21-081C331CE942 Q26991896-7543B171-076C-4297-AC9E-31AF25BC3C2A Q27304934-8C4BD05D-9D71-4BC4-958C-A07FBEBA23FB Q27305076-2FD9EE70-CD26-4730-A69F-2F86AA81EEB9 Q27309214-EB516B2B-36B8-445C-BE04-87F0FA78B2F2 Q27329554-757DE85A-FC85-4FE4-B12E-4EDF6C9671F0 Q27348520-81566743-8055-475A-B01B-BFB25C4F60D2 Q27651106-DD53134F-8B42-4499-BED7-439A134045DB Q27658413-3D0607BE-A38F-46A6-B428-A1A7FF2482E6 Q27663289-9134DDE3-8CCC-457C-93AA-D9EB6356D17E Q27676834-1FF9C9EB-FD57-403E-AD72-925B8926D39D Q27687391-B07F9C14-07CD-485D-B9A0-3C485525721B Q28548477-9DD87BC7-A9FE-443A-A574-BCE7B46F37F2 Q28743086-C3F0B72B-0DF4-4EA0-8578-C5F950DD24EC Q30209342-FD95BB66-AE84-4D1F-AC58-F04AC8EA6F83 Q30226873-081C6206-5745-44DC-BD8D-FC128DCF327D Q30353786-4AD6E95C-9802-4A2B-B375-CBBFCAB6FEAE Q30355817-25586B27-94A6-4EE1-A03B-B6256019B74C Q30365243-45F05732-DCC8-4E57-B029-E104458DB160 Q30366119-48D434F3-3661-4040-8D77-4BA0F7C884C1 Q30373077-263F7C1A-119D-4EDE-8E2C-B3262C880BA3 Q30375872-6579E237-6BE1-4C67-8118-1B6970D3EA54 Q30376369-85080009-4E2E-4E02-889A-DA1335E5CF43 Q30376608-A6D90A6B-05ED-4A80-AA02-683A711012BE Q30377041-AA5DD802-4A29-4161-B96F-0724E8A3A01D Q30381595-2963B175-F714-472A-A913-906750A810FF Q30384441-AD9F70D8-721D-4115-BB15-891C76A7E0F7 Q30384675-F18B91DA-404D-4C0C-AF41-664B879BFCC8 Q30385397-010809DA-C6C0-4D1D-A669-4EA54F304A52 Q30388401-771A4D36-063B-43EE-B4B9-A8991DEEC164 Q30388522-8EBECA62-2E89-46AE-88D1-D9E9A5E47F93 Q30389274-1BD3A570-1EE5-45B8-A2A1-EE7BD3CD07B7 Q30389669-516187B4-2732-482D-9078-8886CB9950FF

P2860

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

http://www.wikidata.org/entity/Q30368335

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cross-recognition of avian H5N ...... ted to human influenza A virus

@ast

Cross-recognition of avian H5N ...... ted to human influenza A virus

@en

type

label

Cross-recognition of avian H5N ...... ted to human influenza A virus

@ast

Cross-recognition of avian H5N ...... ted to human influenza A virus

@en

prefLabel

Cross-recognition of avian H5N ...... ted to human influenza A virus

@ast

Cross-recognition of avian H5N ...... ted to human influenza A virus

@en

P1433

Q30368335-D318BC49-F633-4E41-AEEE-59EDBD0D567B

P1476

Q30368335-E5DA6625-DBAE-4F12-B6D8-AD3F7D98F7DF

P2093

Q30368335-5CBD5479-B19B-4A27-AA40-D8734530B7B4

Q30368335-7A30B811-556D-4230-9A03-E9318AAA55FB

Q30368335-9C95C7E4-0929-42C2-9D79-4ED4F7AB8F2C

Q30368335-C34B031A-E82F-4416-9847-627CB9225C95

Q30368335-CB7D76D8-1FE4-4BD7-B11E-09F2AE1CC3B9

Q30368335-E5AE3116-ACBD-49E8-A0EB-E84554CC9826

P2860

Q30368335-124E53E7-A856-4295-AE5C-683EF7F35BFF

Q30368335-32997B51-ECF0-4A18-BF70-AC3B7E51553A

Q30368335-490B6368-02C9-40B3-96FC-CAF8DBF81B6B

Q30368335-5CE92466-C8B7-45A3-9F38-536EB30D65FF

Q30368335-5D4BB689-B6FC-41E8-8353-EB2A233EB458

Q30368335-618771AF-E902-411D-A11D-96CED3E0CDE6

Q30368335-66533E8F-501E-4832-95DD-156107DDFC5B

Q30368335-715E1490-8642-44D7-A267-2B5BA68A54C8

Q30368335-768B0761-B38E-4A97-8433-C521F457C8B0

Q30368335-8C9CD5CA-C742-44EF-83E8-A833B6FE277F

P304

Q30368335-8AA4536D-7D11-4525-988A-986276D3B16A

P31

Q30368335-44868A40-21F7-408A-8992-234A918D7EE4

P356

Q30368335-11AE6716-F13C-4889-9250-F2887F511BC1

P433

Q30368335-6A1CF55B-4D47-4CD8-BA78-F8B26C7AF235

P478

Q30368335-B5705744-083F-49CC-BAFE-6742E5E2B4E1

P577

Q30368335-A90D906F-098D-4626-96B1-2C1BA49453D9

P698

Q30368335-56E8CC73-163D-41B2-A68F-3289D826873C

P921

Q30368335-47967AAF-7508-47C2-9F12-C5F8C828952F

P932

Q30368335-C3DB89C8-5E87-44F8-B700-BD7FB2167120

P356

P1433

Journal of Virology

P1476

Cross-recognition of avian H5N ...... ted to human influenza A virus

@en

P2093

A D M E Osterhaus

http://www.w3.org/2001/XMLSchema#string

C A van Baalen

http://www.w3.org/2001/XMLSchema#string

G F Rimmelzwaan

http://www.w3.org/2001/XMLSchema#string

G de Mutsert

http://www.w3.org/2001/XMLSchema#string

J H C M Kreijtz

http://www.w3.org/2001/XMLSchema#string

R A M Fouchier

http://www.w3.org/2001/XMLSchema#string

P2860

Avian influenza A (H5N1) age distribution in humans

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Human cytotoxic T-lymphocyte repertoire to influenza A viruses.

Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro.

Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A

The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells.

P304

5161-5166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02694-07

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18353950

http://www.w3.org/2001/XMLSchema#string

P921

P932

2395172

http://www.w3.org/2001/XMLSchema#string